The prize aims to provide visibility and support for academic entrepreneurs and their companies, worldwide.
“We are very proud and appreciative that the quality and value of our research and abilities to realize its potential to make a signicant improvement in the lives of cancer patients has been recognized by an independent panel of experts. Credit is due to Dr. Nataly Kravchenko-Balasha
and her team, who devised the technology at the Hebrew University of Jerusalem and is MEDPNC’s chief scientist.”, said Dr. Gil Pogozelich, Chairman of MEDPNC.
The company specializes in studying personalized treatments for cancer by analyzing the patient-specific protein network structures and has developed a groundbreaking method that proposes the optimal drug combination for each individual patient and predicts the efficacy of the treatment. Based on its research, MEDPNC has developed a purpose-built treatment strategy algorithm using an information-theoretic approach. This development simplifies the detection of unbalanced protein networks in the patient and creates a personalized “barcode” that can predict the efficacy of various treatment options as well as recommending the optimal combination, thus increasing life expectancy.
About the Spinoff Prize
The Spinoff Prize has been established by Springer Nature in partnership with Merck to provide visibility and support for academic entrepreneurs and their companies, worldwide. It focuses on companies commercializing research in four broad categories: pharmaceuticals, agriculture, chemicals and digital technologies. The judging panel is looking for spinoffs that translate original, high-quality scientific research into products and services that address market problems and are well positioned to make a positive impact on society.
About Nature Research
Nature Research is a portfolio of high-quality products and services across the life, physical, chemical and applied sciences – including journals, databases and researcher services – dedicated to serving the scientific community.